Faron Pharma gets US FDA & FIMEA approvals to begin phase I/II bexmarilimab combination study in hematologic malignancies

Faron Pharma gets US FDA & FIMEA approvals to begin phase I/II bexmarilimab combination study in hematologic malignancies

By, Admin 18 May 2022

Faron Pharmaceuticals Ltd., a clinical stage biopharmaceutical company, announces that both the US Food and Drug Administration (FDA) and Finnish Medicines Agency (FIMEA) have cleared Faron's Investigational New Drug (IND) application to begin the company sponsored BEXMAB study. BEXMAB is a novel phase I/II study to assess safety, tolerability and preliminary efficacy of bexmarilimab, Faron's wholly-owned investigational precision cancer immunotherapy, in combination with standard of care (SoC) therapy in patients with relapsed acute myeloid leukaemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukaemia (CML). This marks the first time bexmarilimab will be assessed as part of a clinical study in hematologic malignancies. "We are pleased that our IND application was cleared to proceed, and we can further explore the strong scientific rationale for combining bexmarilimab and azacitidine," said Marie-Louise Fj

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!